Regular Article
Fluorescence-Based Assay for the Interaction of Small Molecules with the Human Renal Organic Anion Transporter 1

https://doi.org/10.1006/abio.2000.4633Get rights and content

Abstract

Secretion of small molecules from the systemic blood circulation into urine is one of the physiologically essential functions of the kidney. The human organic anion transporter (hOAT1) is a key component in the renal tubular secretion of negatively charged molecules including a variety of important therapeutics. In some cases, compounds interacting with hOAT1 may induce pharmacokinetic drug-drug interactions or cause nephrotoxicity. We developed a fluorescence-based, 96-well format assay using CHO cells stably expressing hOAT1, which allows for the evaluation of interactions between small molecules and hOAT1. The assay is based on the inhibition of the transport of 6-carboxyfluorescein, a high-affinity hOAT1 substrate (Km = 3.9 μM), which was identified as one of several fluorescent organic anions. The relative inhibition potency of various known hOAT1 substrates determined using the 6-carboxyfluorescein-based inhibition assay correlated well with their Km values, indicating that the fluorescent assay exhibits a proper specificity. This in vitro assay can be employed to evaluate the mechanism of renal clearance of organic anions, to assess potential drug-drug interactions and/or nephrotoxic effects of various therapeutics, and to screen for novel hOAT1 inhibitors that could serve as efficient nephroprotectants.

References (28)

  • J.B. Pritchard

    Rat renal cortical slices demonstrate p-aminohippurate/glutarate exchange and sodium/glutarate coupled p-aminohippurate transport

    J. Pharmacol. Exp. Ther.

    (1990)
  • M. Hosoyamada et al.

    Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney

    Am. J. Physiol.

    (1999)
  • R. Lu et al.

    Cloning of the human kidney PAH transporter: Narrow substrate specificity and regulation by protein kinase C

    Am. J. Physiol.

    (1999)
  • Cited by (73)

    • Development of a fluorescence-based assay for screening of urate transporter 1 inhibitors using 6-carboxyfluorescein

      2021, Analytical Biochemistry
      Citation Excerpt :

      Therefore, the development of non-radioactive screening methods for URAT1 inhibitors is highly desirable. Cihlar et al. revealed that fluorescein and its analogs are frequently used fluorescent substrates, which can be transported by organic anion transporter 1 (OAT1, SLC22A6) [20]. Since OAT1 and URAT1 belong to the same OATs (SLC22 family), we designed and obtained human embryonic kidney 293T cells that stably express human URAT1 (hURAT1), and chose fluorescein and its analogs as potential substrates to develop a non-radioactive cell-based screening system for URAT1 inhibitors.

    View all citing articles on Scopus
    1

    To whom correspondence should be addressed at Gilead Sciences, 333 Lakeside Dr., Foster City, CA 94404. Fax: (650) 522-4890. E-mail: [email protected].

    View full text